Munich-based startup Alfadocs has completed an extended Series A financing round of €3.7 million. In addition to existing investors Bayern Kapital and BayBG, three international industry experts are participating for the first time: Stefan Margolis, Kai Romberg, and Sascha Pfeiffer. The new investors bring solid experience in healthtech, software-as-a-service (SaaS), and international scaling, and will also support Alfadocs on the board of directors in the future.
The SaaS platform, founded ten years ago, digitalizes administrative processes in private medical and dental practices. Core functions include appointment booking, clinical documentation, billing services, and interfaces to X-ray systems. The cloud-based solution is compatible with standard devices and meets high data protection and compliance requirements. Alfadocs now has over 60 employees at locations in Munich, Milan, and Turin.
Focus on the Italian market
The new capital is intended to accelerate growth in the Italian market in particular. This includes establishing an additional location in another major Italian city. Furthermore, the company plans to advance its platform technologically.
Specifically, AI-based functions for automating clinical workflows and new tools for so-called patient empowerment are at the forefront. Patients will have greater control over their entire treatment – the so-called “patient journey” – in the future. Expanding the app marketplace with currently over 15 applications and expanding the technical team are also part of the growth strategy.
From an investor perspective, the move is viewed positively: Alfadocs has strong product-market fit and addresses central challenges in digital healthcare. The goal is to simplify bureaucratic processes, minimize errors, and increase patient satisfaction. In the long term, the healthtech plans to build on its leading role in private healthcare first in Italy and then scale internationally in the medium term.
